Literature DB >> 32817370

Cutting Edge: Inhibition of Glycogen Synthase Kinase 3 Activity Induces the Generation and Enhanced Suppressive Function of Human IL-10+ FOXP3+-Induced Regulatory T Cells.

Hao Cheng1,2, Lingbiao Wang3, Biaolong Yang4, Dan Li2, Xiaoxia Wang2, Xinnan Liu2, Na Tian5, Qianru Huang2, Ru Feng2, Zhengting Wang6, Rui Liang2, Sheng-Ming Dai5, Ling Lv3, Ji Wu7, Yuan-Sheng Zang8, Bin Li9.   

Abstract

IL-10 is critical for Foxp3+ regulatory T cell (Tregs)-mediated immune suppression, but how to efficiently upregulate IL-10 production in Tregs remains unclear. In this article, we show that human IL-10+ FOXP3+-induced regulatory T cell (iTreg) generation can be dramatically promoted by inhibiting GSK3 activity. IL-10+ FOXP3+ iTregs induced by GSK3 inhibition exhibit classical features of immune-suppressive T cells. We further demonstrate that IL-10+ iTregs exhibit enhanced suppressive function in both IL-10-dependent and -independent manners. The enhanced suppressive function of IL-10+ Tregs is not due to a single factor such as IL-10, although IL-10 may mediate this enhanced suppressive function to some extent. Mechanistically, the increased transcriptional activity of IL-10 promoter and the enhanced expression of C-Maf and BLIMP1 coordinately facilitate IL-10 expression in human iTregs under GSK3 inhibition. Our study provides a new strategy to generate human immune-suppressive IL-10+ FOXP3+ Tregs for immunotherapies.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32817370      PMCID: PMC7477744          DOI: 10.4049/jimmunol.2000136

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3.

Authors:  M Tone; M J Powell; Y Tone; S A Thompson; H Waldmann
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

2.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Authors:  Ashutosh Chaudhry; Robert M Samstein; Piper Treuting; Yuqiong Liang; Marina C Pils; Jan-Michael Heinrich; Robert S Jack; F Thomas Wunderlich; Jens C Brüning; Werner Müller; Alexander Y Rudensky
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

3.  Suppressive regulatory T cell activity is potentiated by glycogen synthase kinase 3{beta} inhibition.

Authors:  Jay A Graham; Michael Fray; Stephanie de Haseth; Kang Mi Lee; Moh-Moh Lian; Catharine M Chase; Joren C Madsen; James Markmann; Gilles Benichou; Robert B Colvin; A Benedict Cosimi; Shaoping Deng; James Kim; Alessandro Alessandrini
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

4.  IL-10 exacerbates xenogeneic GVHD by inducing massive human T cell expansion.

Authors:  Sojan Abraham; Jang-gi Choi; Chunting Ye; N Manjunath; Premlata Shankar
Journal:  Clin Immunol       Date:  2014-11-15       Impact factor: 3.969

5.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.

Authors:  Yuri P Rubtsov; Jeffrey P Rasmussen; Emil Y Chi; Jason Fontenot; Luca Castelli; Xin Ye; Piper Treuting; Lisa Siewe; Axel Roers; William R Henderson; Werner Muller; Alexander Y Rudensky
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

6.  Antigenic experience dictates functional role of glycogen synthase kinase-3 in human CD4+ T cell responses.

Authors:  Carlos A Garcia; Manjunatha R Benakanakere; Pascale Alard; Michelle M Kosiewicz; Denis F Kinane; Michael Martin
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  Glycogen synthase kinase 3β inhibition promotes human iTreg differentiation and suppressive function.

Authors:  Yongxiang Xia; Han Zhuo; Yunjie Lu; Lei Deng; Runqiu Jiang; Long Zhang; Qin Zhu; Liyong Pu; Xuehao Wang; Ling Lu
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

8.  c-Maf regulates IL-10 expression during Th17 polarization.

Authors:  Jiangnan Xu; Yu Yang; Guixing Qiu; Girdhari Lal; Zhihong Wu; David E Levy; Jordi C Ochando; Jonathan S Bromberg; Yaozhong Ding
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin.

Authors:  Georg Stoecklin; Scott A Tenenbaum; Thomas Mayo; Sridar V Chittur; Ajish D George; Timothy E Baroni; Perry J Blackshear; Paul Anderson
Journal:  J Biol Chem       Date:  2008-02-06       Impact factor: 5.157

10.  Human retinoic acid-regulated CD161+ regulatory T cells support wound repair in intestinal mucosa.

Authors:  Giovanni A M Povoleri; Estefania Nova-Lamperti; Cristiano Scottà; Giorgia Fanelli; Yun-Ching Chen; Pablo D Becker; Dominic Boardman; Benedetta Costantini; Marco Romano; Polychronis Pavlidis; Reuben McGregor; Eirini Pantazi; Daniel Chauss; Hong-Wei Sun; Han-Yu Shih; David J Cousins; Nichola Cooper; Nick Powell; Claudia Kemper; Mehdi Pirooznia; Arian Laurence; Shahram Kordasti; Majid Kazemian; Giovanna Lombardi; Behdad Afzali
Journal:  Nat Immunol       Date:  2018-11-05       Impact factor: 25.606

View more
  4 in total

Review 1.  Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.

Authors:  Fathima A Mohamed; Govindarajan Thangavelu; Stephanie Y Rhee; Peter T Sage; Roddy S O'Connor; Jeffrey C Rathmell; Bruce R Blazar
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 8.786

Review 2.  The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection.

Authors:  Zhan Xu; Xue Jiang; Xueyu Dai; Bin Li
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

Review 3.  Tregs in Autoimmunity: Insights Into Intrinsic Brake Mechanism Driving Pathogenesis and Immune Homeostasis.

Authors:  Kyle J Bednar; Jee Ho Lee; Tatiana Ort
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

4.  Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma.

Authors:  Xiaomao Yin; Zaoyu Wang; Jianfeng Wang; Yunze Xu; Wen Kong; Jin Zhang
Journal:  Oncoimmunology       Date:  2021-06-30       Impact factor: 8.110

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.